Research / Provenance first

Every claim should lead to its evidence.

Material statements route to a standardized entity record and then to a primary study, registry, label, or official status source.

Evidence matrix

Compare human and preclinical evidence, FDA status, WADA status, and source coverage across all records.

Open the human-trial and registry subset of sources cited throughout PeptideAgent.

See why oral, topical, intranasal, intravenous, and subcutaneous evidence cannot be pooled.

Separate FDA-approved peptide products from investigational and unapproved research entities.

Inspect every normalized study, registry, label, government record, review, and anti-doping source cited by the site.

See source corrections, evidence-record changes, and dataset releases in chronological order.

SOURCE-BACKED ANSWERS